WHO vaccine-preventable diseases: monitoring system. 2015 global summary

Last updated 28-May-2015 (Data received as of 22-May-2015)
Next overall update July 2015
2014 data are provisional
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 1'7801 Infant (under 12 months) mortality rate: 212
GDP / capita (US$): 4'5711 Child (under 5 years) mortality rate: 242

Population data in thousands3

  2014  2013  2012  2011  2010  2000  1990  1980 
Total population 6'169  6'080  5'992  5'905  5'822  5'101  4'138  3'250 
Births 138  138  139  139  140  142  154  144 
Surviving infants 136  136  136  137  137  138  145  132 
Pop. less than 5 years 681  686  690  689  682  705  692  608 
Pop. less than 15 years 1'995  1'996  2'000  2'005  2'009  2'087  1'903  1'531 
Female 15-49 years 1'686  1'657  1'626  1'595  1'565  1'280  931  708 

Number of reported case

(Click for retrospective incidence data for Nicaragua)
Diphtheria
Japanese encephalitis
Measles 3'784 
Mumps 44  35  52  1'081 
Pertussis 68  87  24  11  2'469 
Polio* 21 
Rubella 326 
Rubella (CRS)
Tetanus (neonatal) 15  157 
Tetanus (total)** 15  362 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Nicaragua)
Vaccine year result method % card seen                                                
BCG 2005  98  ENDESA   80  99*  99*  99*  99*  99*  99*  84  34 
DTP1 2005  98  ENDESA   80  99*  99*  99*  99*  99*  97 
DTP3 2005  95  ENDESA   80  99*  99*  99*  99*  99*  93  70  16 
HepB_BD         
HepB3 2005  95  ENDESA   80  99*  99*  99*  99*  99*  93 
Hib3 2005  95  ENDESA   80  99*  99*  99*  99*  99*  93 
JapEnc         
MCV          99*  99*  99*  99*  99*  99*  83  15 
MCV2          99*  97 
PCV1          99*  99*  99* 
PCV3          99*  99*  99*  91 
Pol3 2005  95  ENDESA   80  99*  99*  99*  99*  99*  93  90  21 
Rota1          99  99*  99*  99*  99* 
Rota_last          99*  99*  99*  98  98 
Rubella1          99*  99*  99*  99*  99* 
TT2plus 2000  42  DHS   79  25  50  29  95 
PAB         
VAD1          99  98  98  99*  97  84 
YFV          99* 
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Nicaragua)
BCG 98  98  98  98  96  84  34 
DTP1 99  99  99  99  97  88  39 
DTP3 98  98  98  98  83  70  16 
HepB3 98  98  98  98  83 
HepB_BD
Hib3 98  98  98  98  83 
MCV 99  99  99  99  86  82  15 
MCV2
PAB 81  81  81  81  83  39 
PCV3 98  98  61 
Pol3 99  99  99  99  85  90  21 
Rota_last 98  98  98  98 

Number of districts in the country 153  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 81
From 80 to 89% 11
From 50 to 79% 7
Less than 50% 1
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2014 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwP 18 months; 6 years; Yes
DTwPHibHepB 2, 4, 6 months; Yes
HepB_adult Yes risk groups
Influenza_Adult Yes adults at risk
Influenza_Pediatric Yes children at risk
MMR 12 months; Yes
MR Yes risk groups
OPV 2, 4, 6 months; Yes
Pneumo_conj 2, 4, 6 months; Yes
Pneumo_ps Yes risk groups > 50 years
Rotavirus 2, 4 months; Yes
Td 10, 20 years; Yes
VitaminA 6 months; 1, 2, 3, 4 years; Yes
YF No travellers to endemic countries

Immunizaton indicators

Indicator Expected answer 2014  2013  2012  2011  2010  2009  2008 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes    Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2'015  2009-2015  2011-2015  2011- 2015  2011-2015  2007 - 2015  2007 - 2011 
Nº of districts with microplans that include activities to raise immunization coverage number 153  18  153  153  153     

System performance

Total Nº districts in country number 153  153  153  153  153  153  153 
Nº districts with DTP3 coverage >=80% number 141  139  143  135  139  140  132 
% of districts with DTP3 coverage >=80% From 0 to 100% 92  91  93  88  91  92  86 
Nº districts with measles (MCV1) coverage >=95% number 120  123  122  108  95  91  100 
% of districts with MCV1 coverage >=95% From 0 to 100% 78  80  80  71  62  59  65 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  No  No  No     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 75  74  39  23  52  65  74 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes     

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.